Myomo (MYO) Total Debt (2017 - 2025)

Myomo (MYO) reported Total Debt of $2.7 million for Q4 2025, up 368.56% quarter-over-quarter from $583333.0 in Q3 2025.

Myomo (MYO) Total Debt (2017 - 2025) Analysis & Trends

Myomo has reported Total Debt for 5 years, with the latest figure at $2.7 million in Q4 2025.

For the quarter ending Q4 2025, Total Debt changed N/A year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (changed N/A YoY), and the FY2025 full-year result was $2.7 million, changed N/A from the prior year.
Total Debt for Q4 2025 stood at $2.7 million, up from $583333.0 in the prior quarter.
The five-year high for Total Debt was $2.7 million in Q4 2025, with the low at $583333.0 in Q3 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	34.05 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	14.72 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	28.07 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	9.48 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.13 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.93 Bn
10	Myomo	49.44 Mn	31.04 Mn	-	2.73 Mn

Historic Data

Download Data

Date	Value
Dec 31, 2025	2.73 Mn
Sep 30, 2025	583,333.00
Jun 30, 2025	2.50 Mn
Jun 30, 2020	78,780.00
Mar 31, 2020	1.43 Mn
Dec 31, 2019	1.27 Mn
Sep 30, 2019	43,942.00
Jun 30, 2019	58,477.00
Mar 31, 2019	157,927.00
Dec 31, 2018	3,661.00
Sep 30, 2018	8,652.00
Jun 30, 2018	21,962.00
Mar 31, 2018	24,623.00
Dec 31, 2017	39,930.00
Sep 30, 2017	968,817.00
Jun 30, 2017	876,458.00